Syndicated Research Studies

The global capnography devices market was valued at USD 676.6 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2030. This growth is expected to be driven by several key factors, including ongoing technological advancements, an increasing prevalence of respiratory conditions, and strong support from government initiatives aimed at improving healthcare outcomes. Capnography devices, which monitor the concentration of carbon dioxide (CO2) in exhaled air, are becoming increasingly integral in managing respiratory diseases. Their proven reliability and efficiency in real-time patient monitoring are expected to further enhance their adoption, improving clinical outcomes. For example, chronic obstructive pulmonary disease (COPD), which includes conditions such as emphysema and chronic bronchitis, affects a significant portion of the population. In 2022, it was reported that 4.6% of adults had been diagnosed with one of these conditions at...

The global market for capnography devices, which was valued at USD 676.6 million in 2023, is projected to experience robust growth at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2030. Several key factors are expected to drive this growth, including technological advancements, a rising prevalence of respiratory conditions, and the support of government initiatives aimed at improving healthcare. The growing use of capnography for the management and monitoring of respiratory diseases is likely to further enhance the clinical effectiveness of these devices. This is primarily due to their proven reliability and efficiency in patient monitoring, which ensures better outcomes in clinical settings. For instance, data from 2022 showed that 4.6% of adults were diagnosed with chronic obstructive pulmonary disease (COPD), emphysema, or chronic bronchitis during their lifetime. Additionally, 4.2% of all office-based physician visits documented COPD in patient records, while approxim...

The global capnography devices market was valued at USD 676.6 million in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2030. This growth is expected to be fueled by advancements in technology, a rising incidence of respiratory conditions, and support from government initiatives. The increasing adoption of capnography for managing respiratory diseases is likely to improve the clinical effectiveness of these devices in patient monitoring due to their proven reliability and efficiency. For example, in 2022, 4.6% of adults were diagnosed with chronic obstructive pulmonary disease (COPD), emphysema, or chronic bronchitis at some point in their lives. Additionally, 4.2% of office-based physician visits documented COPD in medical records, and there were around 791,000 emergency department visits where COPD was the primary reason for seeking care. Technological innovations in capnography, such as the emergence of portable and handheld devices, e...

Capnography Devices  Industry Overview The global capnography devices market size was valued at USD 565.3 million in 2021 and is expected to witness a compound annual growth rate (CAGR) of 9.9% from 2022 to 2030. Technological advancements, the prevalence of respiratory diseases, and supportive government initiatives are anticipated to boost the market growth over the forecast period. The growing adoption of capnography in the treatment of respiratory diseases, due to higher reliability and efficiency, is expected to improve the medical efficiency of these devices in patient monitoring. According to a 2020 report by the Office of Disease Prevention and Health Promotion, more than 25 million people in the U.S. are suffering from asthma. During the COVID-19 pandemic, market players, such as Medtronic, experienced a surge in the demand for capnography devices, among other respiratory system-related products. This was mostly because capnography devices fall under the category of non-in...